GetPortalImpactFactorByIdResp(projectId=1, id=88382877, cover=https://img.medsci.cn/images/journal/cover/2021/FyR_202109271314246440.jpg, fullname=ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, abbr=ASSAY DRUG DEV TECHN, pyear=2002, frequence=Monthly, articleNumbers=786, citedSelf2015=5.0, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=暂无数据, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=1540-658X, greenSci=https://www.greensci.net/search?kw=1540-658X, scijournal=https://www.scijournal.org/impact-factor-of-ASSAY-DRUG-DEV-TECHN.shtml, medsciHotlightString=null, medsciHotlightRealtime=4.276, medsciHotlight=1.438, medsciHotlight5year=2.32578, citescore=2.1, hIndex=56, impactFactor=1.8, orgnization=Mary Ann Liebert Inc., orgnizationUrl=http://www.liebertpub.com, country=United States, countryCn=美国, isOa=0, isOaString=否, sciScie=Science Citation Index Expanded|BIOSIS Previews, bigclassCas=医学 4区, smallclassCas=医学 4 区, website=http://www.liebertpub.com/overview/assay-and-drug-development-technologies/118/, websiteHits=3428, guideForAuthor=null, guideForAuthorHits=1, submitWebsite=https://www.liebertpub.com/forauthors/assay-and-drug-development-technologies/118/, submitWebsiteHits=1278, content=Published by Mary Ann Liebert. ISSN: 1540-658X.<br /><br />ASSAY and Drug Development Technologies, a new peer-reviewed journal, focuses on early-stage screening techniques and tools that optimize the identification of novel leads and targets for new drug development. In addition to original papers and review papers, ASSAY publishes Novel Insights: preliminary studies in methods and technology, and novel uses of instrumentation. Comprehensive technology "workshops" from manufacturers are within the journal's purview and should conform to guidelines for manuscript submission; technical descriptions, applications, discussion, and appropriate case studies will be included., totalCites=1415, brief=ASSAY DRUG DEV TECHN杂志医学行业，“<strong><a target="_blank" href="/sci/index.do?smallclass=生化研究方法" >生化研究方法</a></strong>”子行业的中等级别杂志, articleType=论著，综述各类型文章都接收, medsciHeat=<span style="color: #000000;">黑</span>, medsciComment=杂志水平一般，也很冷门，关注人少，审稿周期可能也不一定快，如果文章质量不佳，或时间不紧的话，可以考虑考虑。, medsciExplanation=MedSci期刊指数是根据中国科研工作者（含医学临床，基础，生物，化学等学科）对SCI杂志的认知度，熟悉程度，以及投稿的量等众多指标综合评定而成。当然，具体的，您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=88382877'>投稿经验系统</a>”，进行综合判断，这更是大家的实战经验，值得分享和参考。<br> 注意，上述MedSci期刊指数采用MedSci专利技术，由计算机系统自动计算，并给出建议，存在不准确的可能，仅供您投稿选择杂志时参考。, tags=null, citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=1.42), GetImpactFactorCiteScoreListResponse(year=2017, citescore=2.07), GetImpactFactorCiteScoreListResponse(year=2018, citescore=1.5), GetImpactFactorCiteScoreListResponse(year=2019, citescore=2.8), GetImpactFactorCiteScoreListResponse(year=2020, citescore=2.1)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=2.6), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=1.384), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=1.103), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=1.183), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=4.276)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Pharmacology, Toxicology and Pharmaceutics - Drug Discovery , rank=93/146), GetImpactFactorCiteScoreGradeResponse(smallClass=Biochemistry, Genetics and Molecular Biology - Molecular Medicine , rank=123/165)], totalJcrAreaList=[GetImpactFactorCiteScoreGradeResponse(smallClass=BIOCHEMICAL RESEARCH METHODS, rank=Q3), GetImpactFactorCiteScoreGradeResponse(smallClass=PHARMACOLOGY & PHARMACY, rank=Q3)], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1540-658X[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES[ta], article_number=34, article_number_cn=2, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)